495 related articles for article (PubMed ID: 17635381)
21. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.
Ringel Y; Ringel-Kulka T
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S145-8. PubMed ID: 21992954
[TBL] [Abstract][Full Text] [Related]
22. Review article: probiotics and prebiotics in irritable bowel syndrome.
Spiller R
Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
[TBL] [Abstract][Full Text] [Related]
23. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.
Kim HJ; Vazquez Roque MI; Camilleri M; Stephens D; Burton DD; Baxter K; Thomforde G; Zinsmeister AR
Neurogastroenterol Motil; 2005 Oct; 17(5):687-96. PubMed ID: 16185307
[TBL] [Abstract][Full Text] [Related]
24. Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome.
Hong YS; Hong KS; Park MH; Ahn YT; Lee JH; Huh CS; Lee J; Kim IK; Hwang GS; Kim JS
J Clin Gastroenterol; 2011; 45(5):415-25. PubMed ID: 21494186
[TBL] [Abstract][Full Text] [Related]
25. Effects of probiotic bacteria in dogs with food responsive diarrhoea treated with an elimination diet.
Sauter SN; Benyacoub J; Allenspach K; Gaschen F; Ontsouka E; Reuteler G; Cavadini C; Knorr R; Blum JW
J Anim Physiol Anim Nutr (Berl); 2006 Aug; 90(7-8):269-77. PubMed ID: 16867072
[TBL] [Abstract][Full Text] [Related]
26. Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebo-controlled randomised study.
Hatakka K; Blomgren K; Pohjavuori S; Kaijalainen T; Poussa T; Leinonen M; Korpela R; Pitkäranta A
Clin Nutr; 2007 Jun; 26(3):314-21. PubMed ID: 17353072
[TBL] [Abstract][Full Text] [Related]
27. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.
Nobaek S; Johansson ML; Molin G; Ahrné S; Jeppsson B
Am J Gastroenterol; 2000 May; 95(5):1231-8. PubMed ID: 10811333
[TBL] [Abstract][Full Text] [Related]
28. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants.
Viljanen M; Kuitunen M; Haahtela T; Juntunen-Backman K; Korpela R; Savilahti E
Pediatr Allergy Immunol; 2005 Feb; 16(1):65-71. PubMed ID: 15693914
[TBL] [Abstract][Full Text] [Related]
29. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.
Søndergaard B; Olsson J; Ohlson K; Svensson U; Bytzer P; Ekesbo R
Scand J Gastroenterol; 2011 Jun; 46(6):663-72. PubMed ID: 21443416
[TBL] [Abstract][Full Text] [Related]
30. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms.
Dughera L; Elia C; Navino M; Cisarò F;
Acta Biomed; 2007 Aug; 78(2):111-6. PubMed ID: 17933278
[TBL] [Abstract][Full Text] [Related]
31. Prescript-assist probiotic-prebiotic treatment for irritable bowel syndrome: an open-label, partially controlled, 1-year extension of a previously published controlled clinical trial.
Bittner AC; Croffut RM; Stranahan MC; Yokelson TN
Clin Ther; 2007 Jun; 29(6):1153-60. PubMed ID: 17692729
[TBL] [Abstract][Full Text] [Related]
32. The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: a randomized, placebo-controlled study.
Roessler A; Forssten SD; Glei M; Ouwehand AC; Jahreis G
Clin Nutr; 2012 Feb; 31(1):22-9. PubMed ID: 21963389
[TBL] [Abstract][Full Text] [Related]
33. Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome.
Brenner DM; Chey WD
Rev Gastroenterol Disord; 2009; 9(1):7-15. PubMed ID: 19367213
[TBL] [Abstract][Full Text] [Related]
34. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial.
de Vrese M; Winkler P; Rautenberg P; Harder T; Noah C; Laue C; Ott S; Hampe J; Schreiber S; Heller K; Schrezenmeir J
Clin Nutr; 2005 Aug; 24(4):481-91. PubMed ID: 16054520
[TBL] [Abstract][Full Text] [Related]
35. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial.
Begtrup LM; de Muckadell OB; Kjeldsen J; Christensen RD; Jarbøl DE
Scand J Gastroenterol; 2013 Oct; 48(10):1127-35. PubMed ID: 23957590
[TBL] [Abstract][Full Text] [Related]
36. Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study.
Colecchia A; Vestito A; La Rocca A; Pasqui F; Nikiforaki A; Festi D;
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):349-58. PubMed ID: 17108864
[TBL] [Abstract][Full Text] [Related]
37. Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infection.
Myllyluoma E; Kajander K; Mikkola H; Kyrönpalo S; Rasmussen M; Kankuri E; Sipponen P; Vapaatalo H; Korpela R
Dig Liver Dis; 2007 Jun; 39(6):516-23. PubMed ID: 17433799
[TBL] [Abstract][Full Text] [Related]
38. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults.
Klein A; Friedrich U; Vogelsang H; Jahreis G
Eur J Clin Nutr; 2008 May; 62(5):584-93. PubMed ID: 17440520
[TBL] [Abstract][Full Text] [Related]
39. Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus.
Collado MC; Jalonen L; Meriluoto J; Salminen S
Asia Pac J Clin Nutr; 2006; 15(4):570-5. PubMed ID: 17077078
[TBL] [Abstract][Full Text] [Related]
40. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.
Ludidi S; Jonkers DM; Koning CJ; Kruimel JW; Mulder L; van der Vaart IB; Conchillo JM; Masclee AA
Neurogastroenterol Motil; 2014 May; 26(5):705-14. PubMed ID: 24588932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
